These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24100630)

  • 1. Aberrant expression of the PRAC gene in prostate cancer.
    Lenka G; Weng WH; Chuang CK; Ng KF; Pang ST
    Int J Oncol; 2013 Dec; 43(6):1960-6. PubMed ID: 24100630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testis specific Y-like 5: gene expression, methylation and implications for drug sensitivity in prostate carcinoma.
    Kumar SR; Bryan JN; Esebua M; Amos-Landgraf J; May TJ
    BMC Cancer; 2017 Feb; 17(1):158. PubMed ID: 28235398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression to metastatic stage in a cellular model of prostate cancer is associated with methylation of the androgen receptor gene and transcriptional suppression of the insulin-like growth factor-I receptor gene.
    Schayek H; Bentov I; Sun S; Plymate SR; Werner H
    Exp Cell Res; 2010 May; 316(9):1479-88. PubMed ID: 20338164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis.
    Tian J; Lee SO; Liang L; Luo J; Huang CK; Li L; Niu Y; Chang C
    J Biol Chem; 2012 Nov; 287(47):39954-66. PubMed ID: 23012352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of resveratrol and antiandrogen flutamide has synergistic effect on androgen receptor inhibition in prostate cancer cells.
    Kai L; Levenson AS
    Anticancer Res; 2011 Oct; 31(10):3323-30. PubMed ID: 21965742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRAC: A novel small nuclear protein that is specifically expressed in human prostate and colon.
    Liu XF; Olsson P; Wolfgang CD; Bera TK; Duray P; Lee B; Pastan I
    Prostate; 2001 May; 47(2):125-31. PubMed ID: 11340635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of androgen regulation of ZEB-1 and PSA in 22RV1 prostate cancer cells.
    Anose BM; LaGoo L; Schwendinger J
    Adv Exp Med Biol; 2008; 617():541-6. PubMed ID: 18497080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells.
    Gravina GL; Festuccia C; Millimaggi D; Dolo V; Tombolini V; de Vito M; Vicentini C; Bologna M
    Prostate; 2008 May; 68(7):793-801. PubMed ID: 18324645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer.
    Mostafavi-Pour Z; Kianpour S; Dehghani M; Mokarram P; Torabinejad S; Monabati A
    Pathol Oncol Res; 2015 Sep; 21(4):921-7. PubMed ID: 25743258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men.
    Devaney JM; Wang S; Furbert-Harris P; Apprey V; Ittmann M; Wang BD; Olender J; Lee NH; Kwabi-Addo B
    Epigenetics; 2015; 10(4):319-28. PubMed ID: 25864488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel androgen receptor target genes in prostate cancer.
    Jariwala U; Prescott J; Jia L; Barski A; Pregizer S; Cogan JP; Arasheben A; Tilley WD; Scher HI; Gerald WL; Buchanan G; Coetzee GA; Frenkel B
    Mol Cancer; 2007 Jun; 6():39. PubMed ID: 17553165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation.
    Tan W; Wang L; Ma Q; Qi M; Lu N; Zhang L; Han B
    Prostate; 2015 Aug; 75(11):1197-205. PubMed ID: 25877612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen.
    Takeda K; Hara N; Nishiyama T; Tasaki M; Ishizaki F; Tomita Y
    BMC Cancer; 2016 May; 16():332. PubMed ID: 27225190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative assessment of AKAP12 promoter methylation in human prostate cancer using methylation-sensitive high-resolution melting: correlation with Gleason score.
    Liu W; Gong J; Hu J; Hu T; Sun Y; Du J; Sun C; Guan M; Jiang H; Lu Y
    Urology; 2011 Apr; 77(4):1006.e1-7. PubMed ID: 21310466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells.
    Mabjeesh NJ; Willard MT; Frederickson CE; Zhong H; Simons JW
    Clin Cancer Res; 2003 Jul; 9(7):2416-25. PubMed ID: 12855613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia.
    Zhong W; Peng J; He H; Wu D; Han Z; Bi X; Dai Q
    Clin Invest Med; 2008; 31(1):E8-E15. PubMed ID: 18312749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the antiandrogen flutamide on the expression of protein kinase C isoenzymes in LNCaP and PC3 human prostate cancer cells.
    Montalvo L; Carmena MJ; Bolaños O; Rodríguez-Henche N; Sánchez-Chapado M; Prieto JC
    Biosci Rep; 2004 Feb; 24(1):11-21. PubMed ID: 15499829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen-induced prostate-specific antigen gene expression is mediated via dihydrotestosterone in LNCaP cells.
    Zhu YS; Cai LQ; You X; Cordero JJ; Huang Y; Imperato-McGinley J
    J Androl; 2003; 24(5):681-7. PubMed ID: 12954658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel synthetic compound that interrupts androgen receptor signaling in human prostate cancer cells.
    Lu S; Wang A; Lu S; Dong Z
    Mol Cancer Ther; 2007 Jul; 6(7):2057-64. PubMed ID: 17620434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.